Alibaba Announces HK$80 Billion Share Placement to Fund AI Capex

What happened

Alibaba announced a proposed placing of newly issued ordinary shares to non-U.S. persons outside the United States with aggregate consideration of HK$80 billion, subject to market conditions. The raise comes as the company's FY2026 free cash flow turned negative by RMB46.6 billion and cash/liquid investments fell to RMB520.8 billion from RMB597.1 billion a year earlier, indicating external funding is now part of the AI infrastructure plan. Investors should treat this as a dilutive signal that management is unwilling to further deplete internal liquidity to sustain the US$53 billion AI buildout. The placement is structured to avoid U.S. registration, which may limit participation and pricing efficiency compared to a broader offering. Cloud demand has been strong, with external revenue up 40% and AI products at 30% of external cloud revenue, but the equity raise shifts the burden to proving those growth dollars convert into per-share value creation.

Implication

The placement adds to share count and reduces existing holders' claim on future earnings, so any upside scenario must now overcome higher per-share hurdle rates. Management's choice to issue equity rather than slow capex suggests the AI investment cycle is not yet peaking, which risks prolonging the gap between revenue growth and cash recovery. If placement proceeds fund additional underutilized capacity, the bear case of structural lower returns becomes more likely. Conversely, if the funds accelerate high-ROI AI services and free cash flow turns positive within FY2027, the dilution could be justified. Until pricing and use of proceeds are disclosed, maintain the WAIT rating and re-evaluate only on evidence that capex intensity is moderating or cloud margins are expanding.

Thesis delta

The prior WAIT thesis was based on balanced risk-reward with the need for cloud monetization to catch up to investment. This equity placement introduces an incremental headwind: dilution lowers per-share value and signals that management prefers external funding over reducing capex or using internal cash. The thesis remains WAIT, but the burden of proof on AI returns is now higher, and the attractive entry could be lower if the raise prices at a discount.